Department of Pulmonology and Respiratory Medicine, University of Sebelas Maret, Surakarta, Central Java, 57126, Indonesia.
Dr Moewardi General Hospital, Surakarta, Central Java, 57126, Indonesia.
Asian Pac J Cancer Prev. 2021 Nov 1;22(11):3455-3460. doi: 10.31557/APJCP.2021.22.11.3455.
To evaluate the effectiveness of cognitive behavior therapy on anxiety, depression, and quality of life of pre-diagnosed lung cancer patients.
A total of 32 pre-diagnosed subjects were divided into 16 Cognitive behaviour theraphy (CBT)-intervention patients and 16 control subjects. The study subjects were pre-diagnosed lung cancer patients hospitalized at Regional Public Hospital Dr. Moewardi Surakarta. For the treatment group, CBT psychotherapy interventions were given for up to 6 sessions every 2 days. The patient was tested for Hamilton Anxiety Rating Scale (HARS)-based anxiety symptom criteria and Hamilton Depression Rating Scale (HRSD)-based depression and followed The World Health Organization Quality of Life- Brief version (WHOQOL-BREF)-based quality of life criteria. The effect of CBT intervention was measured using an independent t-test and the Mann-Whitney test.
There was a significant difference in the intervention group post-test: HARS criteria decreased by -8.38 ± 2.90, HRSD decreased by an average of -6.75 ± 3.30, and WHOQOL-BREF increased by an average of 16.80 ± 10.13 compared with the control group.
CBT affects the improvement of anxiety, depression, and quality of life for pre-diagnosed lung cancer patients.
评估认知行为疗法对确诊前肺癌患者焦虑、抑郁和生活质量的影响。
共纳入 32 名确诊前的受试者,分为 16 名认知行为疗法(CBT)干预组患者和 16 名对照组患者。研究对象为在梭罗地区公立医院 Dr. Moewardi 住院的确诊前肺癌患者。对于治疗组,每两天进行 6 次 CBT 心理治疗干预。患者接受基于汉密尔顿焦虑量表(HARS)的焦虑症状标准、基于汉密尔顿抑郁量表(HRSD)的抑郁标准以及基于世界卫生组织生活质量简表(WHOQOL-BREF)的生活质量标准测试。使用独立 t 检验和曼-惠特尼检验来衡量 CBT 干预的效果。
干预组的测试后有显著差异:HARS 标准降低了-8.38±2.90,HRSD 平均降低了-6.75±3.30,而 WHOQOL-BREF 平均增加了 16.80±10.13,与对照组相比。
CBT 影响了确诊前肺癌患者焦虑、抑郁和生活质量的改善。